✦ LIBER ✦

Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides

✍ Scribed by E. M. Rapoport; G. V. Pazynina; M. A. Sablina; P. R. Crocker; N. V. Bovin

Book ID: 110153602
Publisher: Springer
Year: 2006
Tongue: English
Weight: 206 KB
Volume: 71
Category: Article
ISSN: 0006-2979
DOI: 10.1134/s0006297906050051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular interaction of Siglecs (sialic

Molecular interaction of Siglecs (sialic acid-binding Ig-like lectins) with sialylated ligands on Trypanosoma cruzi

✍ Thomas Jacobs; Hanna Erdmann; Bernhard Fleischer 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 234 KB

Sialylated ligands on pathogenic Trypano

Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E)

✍ Hanna Erdmann; Christiane Steeg; Friedrich Koch-Nolte; Bernhard Fleischer; Thoma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

Polymorphisms in the sialic acid-binding

Polymorphisms in the sialic acid-binding immunoglobulin-like lectin-8 (Siglec-8) gene are associated with susceptibility to asthma

✍ Gao, Pei-Song; Shimizu, Kenichi; Grant, Audrey V; Rafaels, Nicholas; Zhou, Lin-F 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 458 KB

Polymorphisms in the Sialic Acid-binding

Polymorphisms in the Sialic Acid-binding Immunoglobulin-like lectin 8 (SIGLEC8) Gene Are Associated with Asthma in Two Populations.

✍ Shimizu, K.; Gao, P.; Konno, S.; Zhou, L.; Hudson, S.A.; Nishimura, M.; Barnes, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Sialic acid–binding Ig-like lectin 1 exp

Sialic acid–binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus

✍ Robert Biesen; Cemal Demir; Fidan Barkhudarova; Joachim R. Grün; Marta Steinbric 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

## Abstract ## Objective Type I interferon (IFN) plays a pivotal role in the pathogenesis of systemic lupus erythematosus (SLE) and is therefore considered a potential therapeutic target. This study was undertaken to establish a feasible biomarker for IFN effects with respect to disease activity a